指南与共识类风湿关节炎脊柱关节炎系统性红斑狼疮

EULAR风湿病妊娠登记核心数据集推荐

EULAR recommendations for a core data set for pregnancy registries in rheumatology.
指南 / 共识 · Ann Rheum Dis · 2020-10-14

EULAR工作组通过两轮Delphi调查和面对面会议制定风湿病妊娠登记核心数据集,覆盖妊娠期及新生儿28天。64名来自14国的多学科利益相关者参与,共识确定51个主要条目,涵盖母体信息、妊娠和治疗,并为五种最常见炎症性风湿病提出疾病特异性实验室标志物和疾病活动度测量。

要点

  • 共识确定51个主要条目,覆盖母体信息、妊娠和治疗三大领域。
  • 为每种条目推荐通用评估工具,便于跨登记数据合并分析。
  • 针对类风湿关节炎、脊柱关节炎、幼年特发性关节炎、系统性红斑狼疮和其他结缔组织病提出疾病特异性标志物和活动度测量。

核心结论

  • 这是首个基于共识的风湿病前瞻性妊娠登记核心数据集,旨在促进跨国合作以增加对炎症性风湿病患者妊娠过程和治療安全性的认识。

研究设计与样本

  • EULAR工作组采用分步流程,包括两轮Delphi调查和面对面会议达成共识。
  • 64名来自14个不同国家的多学科利益相关者参与了两轮Delphi过程。

主要发现

  • 共识确定51个主要条目,覆盖「母体信息」、「妊娠」和「治疗」。
  • 为每个条目推荐通用评估工具。
  • 针对类风湿关节炎、脊柱关节炎、幼年特发性关节炎、系统性红斑狼疮和其他结缔组织病五种最常见炎症性风湿病,提出疾病特异性实验室标志物和疾病活动度测量。

关键数值与推荐

  • 核心数据集覆盖妊娠期及新生儿28天阶段,适用于任何基础炎症性风湿病的女性。
  • 共识条目总数为51个主要条目。

临床怎么用

  • 风湿病妊娠登记应采用该核心数据集收集数据,以促进未来跨国研究和数据合并分析。
  • 对五种最常见炎症性风湿病,登记时应收集相应的疾病特异性实验室标志物和疾病活动度测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: There is an urgent need for robust data on the trajectories and outcomes of pregnancies in women with inflammatory rheumatic diseases (IRD). In particular when rare outcomes or rare diseases are to be investigated, collaborative approaches are required. However, joint data analyses are often limited by the heterogeneity of the different data sources.To facilitate future research collaboration, a European League Against Rheumatism (EULAR) Task Force defined a core data set with a minimum of items to be collected by pregnancy registries in rheumatology covering the period of pregnancy and the 28-day neonatal phase in women with any underlying IRD. METHODS: A stepwise process included a two-round Delphi survey and a face-to-face meeting to achieve consensus about relevant items. RESULTS: A total of 64 multidisciplinary stakeholders from 14 different countries participated in the two rounds of the Delphi process. During the following face-to-face meeting of the EULAR Task Force, consensus was reached on 51 main items covering 'maternal information', 'pregnancy' and 'treatment'. Generic instruments for assessment are recommended for every item. Furthermore, for the five most frequent IRDs rheumatoid arthritis, spondyloarthritis, juvenile idiopathic arthritis, systemic lupus erythematosus and other connective tissue diseases, disease-specific laboratory markers and disease activity measurements are proposed. CONCLUSION: This is the first consensus-based core data set for prospective pregnancy registries in rheumatology. Its purpose is to stimulate and facilitate multinational collaborations that aim to increase the knowledge about pregnancy course and safety of treatment in women with IRDs during pregnancy.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Meissner Y, Fischer-Betz R, Andreoli L, et al. EULAR recommendations for a core data set for pregnancy registries in rheumatology. Ann Rheum Dis. 2020. PMID: 33055080. doi:10.1136/annrheumdis-2020-218356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。